|

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

RECRUITINGN/ASponsored by Institute of Liver and Biliary Sciences, India
Actively Recruiting
PhaseN/A
SponsorInstitute of Liver and Biliary Sciences, India
Started2024-07-01
Est. completion2025-06-30
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06676813

Summary

The aims of this study are as follows: To compare the role of alternate-day fasting over standard medical management alone to reverse NASH.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 18-65 years. BMI 25-40kg/m3, and CAP more than 290
* Stable weight in the last 3 months prior to enrolling in the study(\<5kg weight variation)
* Imaging showed steatotic liver disease, liver stiffness \<14kPa measured by fibroscan
* Histologically proven NASH/MASH, fibrosis up to F3
* Subjects willing to participate in the study

Exclusion Criter

* Liver stiffness \>14kPa measured by fibroscan or Fibrosis \>F3
* Diabetes with HbA1c\>8.5%
* Patients with another co-existing active liver disease e.g. hepatitis B or C, alcoholic liver disease
* Patients with cirrhosis, hepatocellular carcinoma(HCC), or other malignancy
* Chronic kidney disease, cardiovascular disorders, uncontrolled hypertension
* Chronic infections, chronic inflammatory diseases
* Patients on weight loss medications e.g semaglutide
* Pregnant or lactating women and those planning a pregnancy A patient who is not willing to participate in the study or failed to provide the consent

Conditions2

Liver DiseaseNon-Alcoholic Steatohepatitis

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.